Report cover image

Oncology Drugs Global Market Opportunities And Strategies To 2032

Publisher The Business Research Company
Published Apr 25, 2023
Length 501 Pages
SKU # BRC17888616

Description

Oncology Drugs Global Market Opportunities And Strategies To 2032

Oncology Drugs Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global oncology drugs market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Description:

Where is the largest and fastest growing market for oncology drugs? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The oncology drugs market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider oncology drugs market; and compares it with other markets.

The report covers the following chapters
  • Introduction and Market Characteristics
Brief introduction to the segmentations covered in the market, defintions and explanations about the oncology drugs market.

  • Product Analysis

    • The product analysis section of the report describes the leading products in the oncology drugs market along with key features and differentiators for those products.

  • Supply Chain

    • The supply chain section of the report defines and explains the key players in the oncology drugs industry supply chain.
    • Customer Information
    This chapter covers recent customers’ trends/preferences in the global oncology drugs market.
    • Key Trends
    Highlights the major trends shaping the global oncology drugs market. This section also highlights likely future developments in the market.

  • Global Market Size and Growth

    • Global historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
    • Regional Analysis
    Historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values and growth and market share comparison by region.
    • Market Segmentation
    Contains the market values (2017-2032) and analysis for each segment by type, by distribution channel, by route of administration, by drug classification and by mode of purchase in the market.

  • Regional Market Size and Growth

    • Regional market size (2022), historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and growth and market share comparison of countries within the region. This report includes information on the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
    • Competitive Landscape
    Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
    • Key Mergers and Acquisitions
    Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
    • Market Opportunities And Strategies
    Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
    • Conclusions And Recommendations
    This section Includes recommendations for oncology drugs providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
    • Market Background: Pharmaceutical Drugs Market
    This chapter describes the parent pharmaceutical drugs market of which the oncology drugs market is a segment. This chapter includes the global pharmaceutical drugs market 2017-27 values, and regional and country analyses for the pharmaceutical drugs market.
    • Appendix
    This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

    Scope

    Markets Covered:

    1) By Type: Lung Cancer; Pancreatic Cancer; Breast Cancer; Prostate Cancer; Ovarian Cancer; Colorectal Cancer; Gastric Cancer; Kidney Cancer; Brain Tumor; Thyroid Cancer; Skin Cancer; Bladder Cancer; Cervical Cancer; Blood Cancer; Other Oncology Drugs

    2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/Drug Stores; Other Distribution Channels

    3) By Route Of Administration: Oral; Parental; Other Route Of Administration

    4) By Drug Classification: Branded Drugs; Generic Drugs

    5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

    Companies Mentioned: Bristol-Myers Squibb Company Limited; F. Hoffmann-La Roche AG; Merck & Co. Inc; Novartis AG; Johnson & Johnson

    Countries: Australia; China; Bangladesh; India; Indonesia; Japan; South Korea; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa

    Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

    Time series: Five years historic and ten years forecast.

    Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; oncology drugs indicators comparison.

    Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

    Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

    Table of Contents

    501 Pages
    1. Executive Summary
    2. Table of Contents
    3. List of Figures
    4. List of Tables
    5. Report Structure
    6. Introduction and Market Characteristics
    6.1. General Market Definition
    6.2. Summary
    6.3. Oncology Drugs Market Definition And Segmentations
    6.4. Market Segmentation By Type
    6.4.1. Lung Cancer Drugs
    6.4.2. Pancreatic Cancer Drugs
    6.4.3. Breast Cancer Drugs
    6.4.4. Prostate Cancer Drugs
    6.4.5. Ovarian Cancer Drugs
    6.4.6. Colorectal Cancer Drugs
    6.4.7. Gastric Cancer Drugs
    6.4.8. Kidney Cancer Drugs
    6.4.9. Brain Tumor Drugs
    6.4.10. Thyroid Cancer Drugs
    6.4.11. Skin Cancer Drugs
    6.4.12. Bladder Cancer Drugs
    6.4.13. Cervical Cancer Drugs
    6.4.14. Blood Cancer Drugs
    6.4.15. Other Oncology Drugs
    6.5. Market Segmentation By Distribution Channel
    6.5.1. Hospital Pharmacies
    6.5.2. Retail Pharmacies/Drug Stores
    6.5.3. Other Distribution Channels
    6.6. Market Segmentation By Route Of Administration
    6.6.1. Oral
    6.6.2. Parenteral
    6.6.3. Other Route Of Administration
    6.7. Market Segmentation By Drug Classification
    6.7.1. Branded Drugs
    6.7.2. Generic Drugs
    6.8. Market Segmentation By Mode Of Purchase
    6.8.1. Prescription-Based Drugs
    6.8.2. Over-The-Counter Drugs
    7. Product/Service Analysis –Product/Service Examples
    8. Supply Chain Analysis
    8.1. Raw Material Suppliers
    8.2. Contract Research Organization (CRO)
    8.3. Oncology Drugs Manufacturer
    8.3.1. Drug Discovery
    8.3.2. Preclinical And Clinical Trials
    8.3.3. Patents Upon Discovery And Approval
    8.3.4. Drug Manufacturing
    8.4. Contract Manufacturing Organization (CMO)
    8.5. Wholesalers/Distributors
    8.6. Retailers (Pharmacies) And Hospitals
    8.7. Oncologists
    8.8. End-Users
    9. Customer Information
    9.1. Cancer Patients Are In Need Of Pharma's Support
    9.2. Oncologists Want To Understand More About Precision Medicine Sold To Them
    9.3. Cancer Care Clinicians Are Satisfied With Telehealth And Continue To Use It
    9.4. Patients Have Low Access To High Priority Cancer Medicines
    9.5. Oncology Drug Shortages Are A Growing Concern For Clinical Practice
    9.6. COVID-19 Pandemic Effects On Cancer Patients And Survivors
    9.7. Most People Are Aware Of At Least One Major Cancer Risk Factor
    9.8. COVID-19 Disrupted The Operations Of European Oncology Pharmacies And Clinical Practices
    9.9. Only 17% Of Cancer Patients Receive Correct Treatment
    10. Major Market Trends
    10.1. Investment In Artificial Intelligence For Oncology Drugs
    10.2. Development Of Next Generation Biologics
    10.3. Innovation In Patient Therapies (New Active Substances)
    10.4. CRISPR-Cas9 Technology Use In Cancer Treatment
    10.5. Expansion Of Cell And Gene Therapy & CAR-T Approvals
    10.6. Development Of Personalized Cancer Vaccines
    10.7. Microneedle Pills
    10.8. Rising Focus On Immunotherapy Drugs For Cancer Treatment
    10.9. Development Of Innovative Drugs To Treat Hematopoietic Cancers
    10.10. Collaboration Driving Innovation
    10.11. Rising Focus On Targeted Therapy
    11. Global Oncology Drugs Market Size And Growth
    11.1. Market Size
    11.2. Historic Market Growth, 2017 – 2022, Value ($ Billion)
    11.2.1. Market Drivers 2017 – 2022
    11.2.2. Market Restraints 2017 – 2022
    11.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    11.3.1. Market Drivers 2022 – 2027
    11.3.2. Market Restraints 2022 – 2027
    12. Oncology Drugs Market, Regional Analysis
    12.1. Global Oncology Drugs Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    12.2. Global Oncology Drugs Market, 2017 – 2027, Historic And Forecast, By Region
    12.3. Global Oncology Drugs Market, 2022 – 2027, Growth And Market Share Comparison, By Region
    13. Global Market Segmentation
    13.1. Global Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    13.2. Global Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    13.3. Global Oncology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    13.4. Global Oncology Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    13.5. Global Oncology Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    14. Market Comparison with Macro Economic Factors
    14.1. Oncology Drugs Market Size, Percentage Of GDP, Global
    14.2. Per Capita Average Oncology Drugs Market Expenditure, Global
    15. Asia-Pacific Market
    15.1. Summary
    15.2. Market Overview
    15.2.1. Region Information
    15.2.2. Market Information
    15.2.3. Background Information
    15.2.4. Government Initiatives
    15.2.5. Regulations
    15.2.6. Regulatory Bodies
    15.2.7. Major Associations
    15.2.8. Taxes Levied
    15.2.9. Corporate Tax Structure
    15.2.10. Investments
    15.2.11. Major Companies
    15.3. Asia-Pacific Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    15.4. Asia-Pacific Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    15.5. Asia-Pacific Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    15.6. Asia-Pacific Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    15.7. Asia-Pacific Oncology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    15.8. Asia-Pacific Oncology Drugs Market, 2022, By Country, Value ($ Billion)
    15.9. Asia-Pacific Oncology Drugs Market, 2017 – 2027, Historic And Forecast, By Country
    15.10. Asia-Pacific Oncology Drugs Market, 2022 – 2027, Growth And Market Share Comparison, By Country
    15.11. Asia-Pacific Oncology Drugs Market Metrics
    15.11.1. Per Capita Oncology Drugs Expenditure, 2022, Asia-Pacific Major Countries
    15.12. Asia-Pacific Oncology Drugs Market: Country Analysis
    15.13. Australia Market
    15.14. Australia Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    15.15. Australia Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    15.16. Australia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    15.17. Australia Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    15.18. Australia Oncology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    15.19. Bangladesh Market
    15.20. Bangladesh Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    15.21. Bangladesh Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    15.22. China Market
    15.23. Summary
    15.24. Market Overview
    15.24.1. Country Information
    15.24.2. Market Information
    15.24.3. Background Information
    15.24.4. Government Initiatives
    15.24.5. Regulations
    15.24.6. Regulatory Bodies
    15.24.7. Major Associations
    15.24.8. Taxes Levied
    15.24.9. Corporate Tax Structure
    15.24.10. Investments
    15.24.11. Major Companies
    15.25. China Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    15.26. China Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    15.27. China Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    15.28. China Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    15.29. China Oncology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    15.30. Hong Kong Market
    15.31. Hong Kong Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    15.32. Hong Kong Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    15.33. India Market
    15.34. India Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    15.35. India Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    15.36. India Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    15.37. India Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    15.38. India Oncology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    15.39. Indonesia Market
    15.40. Indonesia Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    15.41. Indonesia Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    15.42. Indonesia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    15.43. Indonesia Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    15.44. Indonesia Oncology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    15.45. Japan Market
    15.46. Japan Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    15.47. Japan Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    15.48. Japan Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    15.49. Malaysia Market
    15.50. Malaysia Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    15.51. Malaysia Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    15.52. New Zealand Market
    15.53. New Zealand Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    15.54. New Zealand Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    15.55. Philippines Market
    15.56. Philippines Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    15.57. Philippines Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    15.58. Singapore Market
    15.59. Singapore Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    15.60. Singapore Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    15.61. South Korea Market
    15.62. South Korea Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    15.63. South Korea Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    15.64. South Korea Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    15.65. South Korea Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    15.66. South Korea Oncology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    15.67. Thailand Market
    15.68. Thailand Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    15.69. Thailand Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    15.70. Vietnam Market
    15.71. Vietnam Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    15.72. Vietnam Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    16. Western Europe Market
    16.1. Summary
    16.2. Market Overview
    16.2.1. Region Information
    16.2.2. Market Information
    16.2.3. Background Information
    16.2.4. Government Initiatives
    16.2.5. Regulations
    16.2.6. Regulatory Bodies
    16.2.7. Major Associations
    16.2.8. Taxes Levied
    16.2.9. Corporate Tax Structure
    16.2.10. Investments
    16.2.11. Major Companies
    16.3. Western Europe Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    16.4. Western Europe Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    16.5. Western Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    16.6. Western Europe Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    16.7. Western Europe Oncology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    16.8. Western Europe Oncology Drugs Market, 2022, By Country, Value ($ Billion)
    16.9. Western Europe Oncology Drugs Market, 2017 – 2027, Historic And Forecast, By Country
    16.10. Western Europe Oncology Drugs Market, 2022 – 2027, Growth And Market Share Comparison, By Country
    16.11. Western Europe Oncology Drugs Market Metrics
    16.11.1. Per Capita Oncology Drugs Expenditure, 2022, Western Europe Major Countries
    16.12. Western Europe Oncology Drugs Market: Country Analysis
    16.13. Austria Market
    16.14. Austria Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    16.15. Austria Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    16.16. Belgium Market
    16.17. Belgium Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    16.18. Belgium Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    16.19. Denmark Market
    16.20. Denmark Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    16.21. Denmark Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    16.22. Finland Market
    16.23. Finland Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    16.24. Finland Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    16.25. France Market
    16.26. France Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    16.27. France Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    16.28. France Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    16.29. France Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    16.30. France Oncology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    16.31. Germany Market
    16.32. Germany Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    16.33. Germany Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    16.34. Germany Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    16.35. Germany Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    16.36. Germany Oncology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    16.37. Ireland Market
    16.38. Ireland Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    16.39. Ireland Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    16.40. Italy Market
    16.41. Italy Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    16.42. Italy Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    16.43. Netherlands Market
    16.44. Netherlands Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    16.45. Netherlands Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    16.46. Norway Market
    16.47. Norway Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    16.48. Norway Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    16.49. Portugal Market
    16.50. Portugal Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    16.51. Portugal Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    16.52. Spain Market
    16.53. Spain Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    16.54. Spain Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    16.55. Sweden Market
    16.56. Sweden Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    16.57. Sweden Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    16.58. Switzerland Market
    16.59. Switzerland Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    16.60. Switzerland Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    16.61. UK Market
    16.62. UK Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    16.63. UK Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    16.64. UK Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    16.65. UK Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    16.66. UK Oncology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    17. Eastern Europe Market
    17.1. Summary
    17.2. Market Overview
    17.2.1. Region Information
    17.2.2. Market Information
    17.2.3. Background Information
    17.2.4. Government Initiatives
    17.2.5. Regulations
    17.2.6. Regulatory Bodies
    17.2.7. Major Associations
    17.2.8. Taxes Levied
    17.2.9. Corporate Tax Structure
    17.2.10. Investments
    17.2.11. Major Companies
    17.3. Eastern Europe Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    17.4. Eastern Europe Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    17.5. Eastern Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    17.6. Eastern Europe Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    17.7. Eastern Europe Oncology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    17.8. Eastern Europe Oncology Drugs Market, 2022, By Country, Value ($ Billion)
    17.9. Eastern Europe Oncology Drugs Market, 2017 – 2027, Historic And Forecast, By Country
    17.10. Eastern Europe Oncology Drugs Market, 2022 – 2027, Growth And Market Share Comparison, By Country
    17.11. Eastern Europe Oncology Drugs Market Metrics
    17.11.1. Per Capita Oncology Drugs Expenditure, 2022, Eastern Europe Major Countries
    17.12. Eastern Europe Oncology Drugs Market: Country Analysis
    17.13. Czech Republic Market
    17.14. Czech Republic Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    17.15. Czech Republic Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    17.16. Poland Market
    17.17. Poland Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    17.18. Poland Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    17.19. Romania Market
    17.20. Romania Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    17.21. Romania Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    17.22. Russia Market
    17.23. Russia Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    17.24. Russia Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    17.25. Russia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    17.26. Russia Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    17.27. Russia Oncology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    17.28. Ukraine Market
    17.29. Ukraine Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    17.30. Ukraine Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    18. North America Market
    18.1. Summary
    18.2. Market Overview
    18.2.1. Region Information
    18.2.2. Market Information
    18.2.3. Background Information
    18.2.4. Government Initiatives
    18.2.5. Regulations
    18.2.6. Regulatory Bodies
    18.2.7. Major Associations
    18.2.8. Taxes Levied
    18.2.9. Corporate Tax Structure
    18.2.10. Investments
    18.2.11. Major Companies
    18.3. North America Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    18.4. North America Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    18.5. North America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    18.6. North America Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    18.7. North America Oncology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    18.8. North America Oncology Drugs Market, 2022, By Country, Value ($ Billion)
    18.9. North America Oncology Drugs Market, 2017 – 2027, Historic And Forecast, By Country
    18.10. North America Oncology Drugs Market, 2022 – 2027, Growth And Market Share Comparison, By Country
    18.11. North America Oncology Drugs Market Metrics
    18.11.1. Per Capita Oncology Drugs Expenditure, 2022, North America Major Countries
    18.12. North America Oncology Drugs Market: Country Analysis
    18.13. Canada Market
    18.14. Canada Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    18.15. Canada Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    18.16. Mexico Market
    18.17. Mexico Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    18.18. Mexico Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    18.19. USA Market
    18.20. Summary
    18.21. Market Overview
    18.21.1. Country Information
    18.21.2. Market Information
    18.21.3. Background Information
    18.21.4. Government Initiatives
    18.21.5. Regulations
    18.21.6. Regulatory Bodies
    18.21.7. Major Associations
    18.21.8. Taxes Levied
    18.21.9. Corporate Tax Structure
    18.21.10. Investments
    18.21.11. Major Companies
    18.22. USA Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    18.23. USA Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    18.24. USA Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    18.25. USA Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    18.26. USA Oncology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    19. South America Market
    19.1. Summary
    19.2. Market Overview
    19.2.1. Region Information
    19.2.2. Market Information
    19.2.3. Background Information
    19.2.4. Government Initiatives
    19.2.5. Regulations
    19.2.6. Regulatory Bodies
    19.2.7. Major Associations
    19.2.8. Taxes Levied
    19.2.9. Corporate Tax Structure
    19.2.10. Investments
    19.2.11. Major Companies
    19.3. South America Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    19.4. South America Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    19.5. South America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    19.6. South America Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    19.7. South America Oncology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    19.8. South America Oncology Drugs Market, 2022, By Country, Value ($ Billion)
    19.9. South America Oncology Drugs Market, 2017 – 2027, Historic And Forecast, By Country
    19.10. South America Oncology Drugs Market, 2022 – 2027, Growth And Market Share Comparison, By Country
    19.11. South America Oncology Drugs Market Metrics
    19.11.1. Per Capita Oncology Drugs Expenditure, 2022, South America Major Countries
    19.12. South America Oncology Drugs Market: Country Analysis
    19.13. Argentina Market
    19.14. Argentina Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    19.15. Argentina Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    19.16. Brazil Market
    19.17. Brazil Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    19.18. Brazil Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    19.19. Brazil Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    19.20. Brazil Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    19.21. Brazil Oncology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    19.22. Chile Market
    19.23. Chile Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    19.24. Chile Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    19.25. Colombia Market
    19.26. Columbia Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    19.27. Columbia Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    19.28. Peru Market
    19.29. Peru Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    19.30. Peru Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    20. Middle East Market
    20.1. Summary
    20.2. Market Overview
    20.2.1. Region Information
    20.2.2. Market Information
    20.2.3. Background Information
    20.2.4. Government Initiatives
    20.2.5. Regulations
    20.2.6. Regulatory Bodies
    20.2.7. Major Associations
    20.2.8. Taxes Levied
    20.2.9. Corporate Tax Structure
    20.2.10. Investments
    20.2.11. Major Companies
    20.3. Middle East Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    20.4. Middle East Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    20.5. Middle East Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    20.6. Middle East Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    20.7. Middle East Oncology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Billion)
    20.8. Middle East Oncology Drugs Market, 2022, By Country, Value ($ Billion)
    20.9. Middle East Oncology Drugs Market, 2017 – 2027, Historic And Forecast, By Country
    20.10. Middle East Oncology Drugs Market, 2022 – 2027, Growth And Market Share Comparison, By Country
    20.11. Middle East Oncology Drugs Market Metrics
    20.11.1. Per Capita Oncology Drugs Expenditure, 2022, Middle East Major Countries
    20.12. Middle East Oncology Drugs Market: Country Analysis
    20.13. Iran Market
    20.14. Iran Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    20.15. Iran Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    20.16. Israel Market
    20.17. Israel Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    20.18. Israel Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    20.19. Saudi Arabia Market
    20.20. Saudi Arabia Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    20.21. Saudi Arabia Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    20.22. Turkey Market
    20.23. Turkey Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    20.24. Turkey Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    20.25. UAE Market
    20.26. UAE Oncology Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Billion)
    20.27. UAE Oncology Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Billion)
    21. Africa Market
    21.1. Summary
    21.2. Market Overview
    21.2.1. Region Information
    21.2.2. Market Information
    21.2.3. Background Information
    21.2.4. Government Initiatives
    21.2.5. Regulations
    21.2.6. Regulatory Bodies
    21.2.7. Major Associations
    21.2.8. Taxes Levied
    21.2.9. Corporate Tax Structure
    21.2.10. Investments
    21.2.11. Major Companies

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us